BioNexus Gene Lab (BGLC) Asset Writedowns and Impairment (2022 - 2026)
BioNexus Gene Lab (BGLC) posted Asset Writedowns and Impairment of $202497.0 for Q1 2026, up 193.77% sequentially from -$215942.0 in Q4 2025, and up 404.68% YoY from $40124.0 in Q1 2025.
BioNexus Gene Lab (BGLC) Asset Writedowns and Impairment (2022 - 2026) Analysis & Trends
BioNexus Gene Lab has reported Asset Writedowns and Impairment for 5 years, with the latest figure at $202497.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment rose 404.68% year-over-year to $202497.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $162373.0 (down 79.83% YoY) and the FY2024 annual result came in at $883533.0, up 14164.34% from the prior year.
- Asset Writedowns and Impairment advanced to $202497.0 in Q1 2026 per BGLC's latest filing, from -$215942.0 in the prior quarter.
- Over five years, Asset Writedowns and Impairment peaked at $760690.0 in Q4 2024 and troughed at -$215942.0 in Q4 2025.
- A 5-year average of $107982.4 and a median of $4165.0 in 2022 frame the typical range for Asset Writedowns and Impairment.
- The sharpest annual moves came in 2024 and 2025: Asset Writedowns and Impairment soared 37576.57% in 2024, then plunged 128.39% in 2025.
- Over 5 years, Asset Writedowns and Impairment stood at $4165.0 in 2022, then sank by 51.52% to $2019.0 in 2023, then jumped by 37576.57% to $760690.0 in 2024, then slumped by 128.39% to -$215942.0 in 2025, then soared by 193.77% to $202497.0 in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $202497.0, -$215942.0, and $175818.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 225.67 Bn | 220.77 Bn | 4.43 Bn |
| 2 | Sherwin Williams | 84.74 Bn | 84.44 Bn | 3.34 Bn |
| 3 | Ecolab | 78.90 Bn | 73.77 Bn | 1.95 Bn |
| 4 | Air Products & Chemicals | 68.19 Bn | 67.21 Bn | 1.04 Bn |
| 5 | Ppg Industries | 25.36 Bn | 23.77 Bn | 1.81 Bn |
| 6 | Chemical & Mining Co Of Chile | 23.48 Bn | 19.61 Bn | 778.60 Mn |
| 7 | LyondellBasell Industries | 21.91 Bn | 19.28 Bn | 2.04 Bn |
| 8 | International Flavors & Fragrances | 21.51 Bn | 20.94 Bn | 853.00 Mn |
| 9 | DuPont de Nemours | 18.83 Bn | 17.09 Bn | 639.00 Mn |
| 10 | BioNexus Gene Lab | 2.28 Mn | -1.25 Mn | 12,982.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 202,497.00 |
| Mar 31, 2026 | 202,497.00 |
| Dec 31, 2025 | -215,942.00 |
| Dec 31, 2025 | -215,942.00 |
| Sep 30, 2025 | 175,818.00 |
| Sep 30, 2025 | 175,818.00 |
| Mar 31, 2025 | 40,124.00 |
| Mar 31, 2025 | 40,124.00 |
| Dec 31, 2024 | 760,690.00 |
| Dec 31, 2024 | 760,690.00 |
| Sep 30, 2024 | 2,374.00 |
| Sep 30, 2024 | 2,374.00 |
| Dec 31, 2023 | 2,019.00 |
| Dec 31, 2023 | 2,019.00 |
| Sep 30, 2023 | 97.00 |
| Sep 30, 2023 | 97.00 |
| Dec 31, 2022 | 4,165.00 |
| Dec 31, 2022 | 4,165.00 |